Paroxetine can improve primary visual cortex activity in a high-risk mouse model of schizophrenia-Reference-Cited by-同舟云学术

Paroxetine can improve primary visual cortex activity in a high-risk mouse model of schizophrenia

Published:2020-01-01 Issue:1 Volume:34 Page:1299-1303
ISSN:1310-2818
Container-title:Biotechnology & Biotechnological Equipment
language:en
Short-container-title:Biotechnology & Biotechnological Equipment

Author:

Chen Xinying¹,Cai Ziyao²,Ji Feng³,Lin Xiaodong²,Jiang Deguo²,Lin Chongguang²,Ma Xiaoyan¹,Xu Yong⁴⁵,Wang Wenqiang⁶,Zheng Lidan¹,Chen Ce¹,Zhuo Chuanjun¹²³⁷^ORCID

Affiliation:

1. Department of Psychiatric-Neuroimging-Genetics and Comorbidity Laboratory (PNGC_Lab), Tianjin Anding Hospital, Tianjin, PR China

2. Department of Psychiatry and Micro-imaging Centre, Wenzhou Seventh People’s Hospital, Wenzhou, PR China

3. Department of Psychiatry, School of Mental Health, Jining Medical University, Jining, PR China

4. Department of Psychiatry, First Hospital/First Clinical Medical College of Shanxi Medical University, Taiyuan, PR China

5. MDT Center for Cognitive Impairment and Sleep Disorders, First Hospital of Shanxi Medical University, Taiyuan, PR China

6. Canada and China Joint Laboratory of Biological Psychiatry, Xiamen Xianye Hospital, Xiamen, Fujian, PR China;

7. Key Laboratory of Real Time Brain Circuits Tracing Of Neurology and Psychiatry (RTBNB_Lab), Tianjin fourth center Hospital, Tianjin Medical affiliated Tianjin Fourth Central Hospital, Nankai University affiliated Tianjin Fourth Center Hospital, Tianjin, PR China

Funder

National Natural Science Foundation of China

Key Projects of the Natural Science Foundation of Tianjin, China

Tianjin Health Bureau Foundation

National Key Research and Development Program of China

Shanxi Science and Technology Innovation Training Team’s Multidisciplinary Team for Cognitive Impairment

Zhejiang Public Welfare Fund Project

Wenzhou Science and Technology Bureau

Publisher

Informa UK Limited

Subject

Biotechnology